Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Legend Biotech Corporation (LEGN)

30.71   -0.38 (-1.22%) 09-29 01:05
Open: 31.08 Pre. Close: 31.09
High: 31.455 Low: 30.13
Volume: 58,983 Market Cap: 3,969M
Legend Biotech Corp is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, LCAR-B38M/JNJ-4528, is an autologous CAR-T cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in a number of hematologic malignancies including multiple myeloma (MM). The Company have a portfolio of earlier-stage autologous product candidates targeting various cancers, including Non-Hodgkins Lymphoma (NHL), Acute Myeloid Leukemia (AML), and T cell Lymphoma (TCL). It is also developing an allogeneic CAR-T product candidate targeting CD20 for the treatment of NHL. The Company also has product candidates in early preclinical and clinical development for the treatment of solid tumors as well as infectious diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 31.487 - 31.653 31.653 - 31.794
Low: 29.744 - 29.929 29.929 - 30.086
Close: 30.404 - 30.72 30.72 - 30.989

Technical analysis

as of: 2020-09-28 4:34:41 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 42.62     One year: 49.78
Support: Support1: 29.17    Support2: 24.64
Resistance: Resistance1: 36.49    Resistance2: 42.62
Pivot: 30.61
Moving Average: MA(5): 29.76     MA(20): 30.87
MA(100):     MA(250):
MACD: MACD(12,26): -0.85     Signal(9): -0.88
Stochastic oscillator: %K(14,3): 61.58     %D(3): 54.56
RSI: RSI(14): 47.24
52-week: High: 43.24  Low: 24.64  Change(%): -17.0
Average Vol(K): 3-Month: 21192  10-Days: 42175

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
LEGN has closed below upper band by 48.6%. Bollinger Bands are 0% narrower than normal.

Headline News

Mon, 28 Sep 2020
Legend Biotech to Participate in the Jefferies Virtual Cell Therapy Summit - Odessa American

Sat, 26 Sep 2020
ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Legend Biotech Corporation - LEGN - Yahoo Finance

Fri, 25 Sep 2020
ROSEN LAW FIRM, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Legend Biotech Corporation – LEGN - Business Wire

Fri, 25 Sep 2020
Legend Biotech Corporation Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire

Wed, 23 Sep 2020
Glancy Prongay & Murray LLP Continues Investigation on Behalf of Legend Biotech Corporation Investors (LEGN) - Business Wire

Wed, 23 Sep 2020
Legend Biotech (LEGN) in Focus: Stock Moves 6.2% Higher - Yahoo Finance

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 129
Shares Float (M) 26
% Held by Insiders
% Held by Institutions
Shares Short (K) 696
Shares Short P. Month (K) 231

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin -312.19
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth 15.0
Gross Profit (p.s.) 0.456
Sales Per Share 0.479
EBITDA (p.s.) -1.446
Qtrly Earnings Growth
Operating Cash Flow (M) -143
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales 64.07
Price to Cash Flow -27.81

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.